Sf. Kozak et al., THE ROLE OF COPPER ON ETHAMBUTOLS ANTIMICROBIAL ACTION AND IMPLICATIONS FOR ETHAMBUTOL-INDUCED OPTIC NEUROPATHY, Diagnostic microbiology and infectious disease, 30(2), 1998, pp. 83-87
The principal side effect of the antimycobacterial agent ethambutol (E
MB) is an optic neuropathy with clinical features very similar to a mi
tochondrial hereditary optic neuropathy (Leber's). The mechanism of EM
B-induced optic neuropathy may be EMB's chelation of copper, thereby p
recluding normal cytochrome c oxidase activity and mitochondrial metab
olism in the optic nerve. Before attempting to use therapeutic copper
to replenish endogenous stoves in an attempt to preclude EMB-induced o
ptic neuropathy, we wished to determine whether EMB is still effective
against mycobacteria in the presence of copper. EMB and copper, alone
and in combination, were tested against six strains of Mycobacterium
tuberculosis and five strains of Mycobacterium avium using a radiometr
ic broth macrodilution assay. Copper did not effect EMB's antimicrobia
l actions against either species of mycobacteria. This in vitro study
suggests that if copper were given to patients to prevent EMB-induced
optic neuropathy it would not compromise EMB's bacteriostatic properti
es. (C) 1998 Elsevier Science Inc.